Abstract | BACKGROUND AND PURPOSE: METHODS: 505 patients (419 Chinese, 41 Malays and 45 Indians) with ischemic stroke were randomized to receive placebo or B-vitamins. Fasting blood samples collected at baseline and 1 year were assayed for tHcy. MTHFR polymorphisms were genotyped. RESULTS: Ethnicity did not independently determine tHcy at baseline. The magnitude of tHcy reduction by B-vitamin treatment was consistent across ethnic groups (Chinese -3.8+/-4.5, Malay -4.9+/-4.2, and Indian -3.3+/-3.6 micromol/L) despite ethnic differences in MTHFR genotype and baseline folic acid (FA) and vitamin B(12) (vitB(12)) concentrations. CONCLUSIONS: Ethnicity does not appear to affect the tHcy-lowering effect of B-vitamins, despite differences in dietary intake and prevalence of MTHFR polymorphisms. This suggests that the effect of B-vitamins in lowering tHcy is generalizable across Asian populations. However, due to relatively small numbers of non-Chinese studied, confirmation in other populations is required.
|
Authors | Katherine Kasiman, John W Eikelboom, Graeme J Hankey, Samantha P-K Lee, Joanna P-Z Lim, Jasinda H-Q Lee, Hui-Meng Chang, Meng-Cheong Wong, Christopher P L-H Chen |
Journal | Stroke
(Stroke)
Vol. 40
Issue 6
Pg. 2209-11
(Jun 2009)
ISSN: 1524-4628 [Electronic] United States |
PMID | 19372453
(Publication Type: Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Homocysteine
- Vitamin B Complex
- Folic Acid
- Methylenetetrahydrofolate Reductase (NADPH2)
|
Topics |
- Aged
- China
(ethnology)
- Diet
- Ethnicity
- Female
- Folic Acid
(blood)
- Gene Frequency
- Genotype
- Homocysteine
(antagonists & inhibitors, blood)
- Humans
- India
(ethnology)
- Malaysia
(ethnology)
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Middle Aged
- Risk Factors
- Singapore
(epidemiology)
- Stroke
(blood)
- Vitamin B Complex
(therapeutic use)
|